Cargando…

Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus

Ebola virus (EBOV) infection in humans and non-human primates (NHPs) is highly lethal, and there is limited understanding of the mechanisms associated with pathogenesis and survival. Here, we describe a transcriptomic analysis of NHPs that survived lethal EBOV infection, compared to NHPs that did no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garamszegi, Sara, Yen, Judy Y., Honko, Anna N., Geisbert, Joan B., Rubins, Kathleen H., Geisbert, Thomas W., Xia, Yu, Hensley, Lisa E., Connor, John H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117489/ https://www.ncbi.nlm.nih.gov/pubmed/25079789 http://dx.doi.org/10.1371/journal.pntd.0003061

Ejemplares similares

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
por: Cross, Robert W., et al.
Publicado: (2016)

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
por: Geisbert, Thomas W, et al.
Publicado: (2010)

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
por: Woolsey, Courtney, et al.
Publicado: (2022)

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
por: Kuang, Erin, et al.
Publicado: (2022)

The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever
por: Rubins, Kathleen H, et al.
Publicado: (2007)

Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2014)

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2012)

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans
por: Cross, Robert W, et al.
Publicado: (2018)

Transcriptional Profiling of the Circulating Immune Response to Lassa Virus in an Aerosol Model of Exposure
por: Malhotra, Shikha, et al.
Publicado: (2013)

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses
por: Daaboul, George G., et al.
Publicado: (2017)

Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection
por: Caballero, Ignacio S, et al.
Publicado: (2014)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

Postexposure Treatment of Marburg Virus Infection
por: Geisbert, Thomas W., et al.
Publicado: (2010)

Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication
por: Olsen, Michelle E., et al.
Publicado: (2016)

Bundibugyo ebolavirus Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling
por: Woolsey, Courtney, et al.
Publicado: (2021)

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
por: Sullivan, Nancy J., et al.
Publicado: (2003)

Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus Infection
por: Geisbert, Thomas W., et al.
Publicado: (2010)

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
por: Cross, Robert W., et al.
Publicado: (2021)

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
por: Mire, Chad E., et al.
Publicado: (2019)

Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression
por: Dower, Ken, et al.
Publicado: (2011)

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
por: Mire, Chad E., et al.
Publicado: (2015)

Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
por: Hensley, Lisa E., et al.
Publicado: (2010)

Correction for Olsen et al., “Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication”
por: Olsen, Michelle E., et al.
Publicado: (2018)

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
por: Callendret, Benoit, et al.
Publicado: (2018)

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
por: Woolsey, Courtney, et al.
Publicado: (2018)

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy
por: Mire, Chad E., et al.
Publicado: (2016)

Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates
por: Thi, Emily P., et al.
Publicado: (2015)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
por: Callendret, Benoit, et al.
Publicado: (2018)

Effective Post-Exposure Treatment of Ebola Infection
por: Feldmann, Heinz, et al.
Publicado: (2007)

Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
por: Brannan, Jennifer M., et al.
Publicado: (2019)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
por: Woolsey, Courtney, et al.
Publicado: (2022)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
por: Geisbert, Thomas W., et al.
Publicado: (2002)

Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs
por: Sullivan, Nancy J, et al.
Publicado: (2006)

Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses
por: Swetha, Rayapadi G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u32bhasi4vau2r8aao4bn52bsb